Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
FROM:
Ursula Parks, Director, Legislative Budget Board
IN RE:
SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), As Introduced
No significant fiscal implication to the State is anticipated.
The bill would amend the Occupations Code relating to prescription and substitution requirements for biological products. Based on information provided by the Board of Pharmacy, it is assumed that the provisions of the bill could be implemented by utilizing existing agency resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.